Global Fmd Vaccine Market
Market Size in USD Billion
CAGR :
% 
USD
3.02 Billion
USD
5.19 Billion
2025
2033
 Forecast Period |
2026 - 2033 |
 Market Size (Base Year) |
USD 3.02 Billion |
 Market Size (Forecast Year) |
USD 5.19 Billion |
 CAGR |
% |
| Major Markets Players |
|
FMD Vaccine Market Size
- The FMD Vaccine Market size was valued at USD 3.02 Billion in 2025and is expected to reach USD 5.19 Billion by 2033, at a CAGR of 7.1% during the forecast period
- The Global Foot-and-Mouth Disease (FMD) Vaccine Market is witnessing steady growth, driven by the high prevalence of Foot-and-Mouth Disease across major livestock-producing. The market is expanding due to increasing vaccination programs, rising demand for animal protein, and strong government initiatives focused on disease control and livestock health management.
- Market expansion is supported by growing investments in veterinary healthcare infrastructure, awareness regarding transboundary animal diseases, and the implementation of mass immunization campaigns. Advancements in multivalent vaccines, improved cold chain logistics, and public-private partnerships are expected to further drive the FMD vaccine market across the Global
FMD Vaccine Market Analysis
- The Global Foot-and-Mouth Disease (FMD) Vaccine market is experiencing steady expansion driven by the high incidence of FMD outbreaks and the growing need for livestock protection across key economies. Rising demand for animal protein and increasing focus on food security are further supporting market growth.
- The Asia-Pacific region holds 38.50% market share in 2025 and is projected to register a CAGR of 7.5%, supported by large-scale government vaccination programs, strengthening veterinary healthcare infrastructure, and rising awareness regarding transboundary animal diseases.
- Asia-Pacific is emerging as one of the fastest-growing countries in the Global Foot-and-Mouth Disease (FMD) Vaccine Market, projected to grow at a CAGR of 7.5% during the forecast period. The country’s strong growth is primarily driven by the high prevalence of FMD outbreaks, increasing government-led livestock vaccination campaigns, and rising investments in veterinary healthcare infrastructure.
- Market growth is fueled by increasing government initiatives for disease eradication, expansion of livestock farming, and rising investments in veterinary biologics. Programs such as mass vaccination drives and surveillance systems are playing a critical role in controlling outbreaks and ensuring herd immunity.
- The market is witnessing advancements in vaccine development, including improved antigen stability, multivalent formulations, and enhanced cold chain logistics. Growing collaboration between public and private stakeholders and rising adoption of advanced veterinary healthcare solutions are expected to drive sustained growth across the Global
- The Conventional Vaccines segment dominated with 76.22% share in 2025 and expected to grow at a CAGR of 6.9%, owing to their widespread availability, established efficacy, and cost-effectiveness in large-scale immunization campaigns across developing economies.
Report Scope and FMD Vaccine Market Segmentation
|
Attributes |
FMD Vaccine Market Insights |
|
Segments Covered |
|
|
Countries Covered |
North America · U.S. · Canada · Mexico Europe · France · Germany · Russia · Italy · Spain · Turkey · U.K. · Netherlands · Denmark · Switzerland · Belgium · Sweden · Norway · Finland · Rest Of Europe Asia-Pacific · China · India · Japan · Australia · South Korea · Indonesia · Thailand · Taiwan · Singapore · New Zealand · Malaysia · Philippines · Hong Kong · Rest of Asia-Pacific South America · Brazil · Argentina · Colombia · Peru · Chile · Ecuador · Venezuela · Bolivia · Uruguay · Paraguay · Rest of South America Middle East and Africa · South Africa · Egypt · Saudi Arabia · United Arab Emirates · Israel · Bahrain · Kuwait · Oman · Qatar · Rest of Middle East & Africa |
|
Key Market Players |
· Boehringer Ingelheim (Germany) · Ceva Santé Animale (France) · Biogénesis Bagó (Argentina) · Indian Immunologicals Ltd. (India) · China Animal Husbandry Industry Co., Ltd. (CAHIC) (China) · Zoetis (U.S.) · Botswana Vaccine Institute (Botswana) · Brilliant Bio Pharma Ltd. (India) · Vetal Animal Health (India) · Vecol S.A. (Colombia) · Biovet Pvt. Ltd. (India) · Limor de Colombia (Colombia) · MEVAC (Egypt) · Kenya Veterinary Vaccines Production Institute (Kenya) · Wuhan Institute of Biological Products Co., Ltd. (China) · Shanghai Shen Lian Biomedical Corporation (China) · Shchelkovo Biocombinat (Russia) · Dollvet (Turkey) · Enimmune Corp. (South Korea) · National Veterinary Institute (Poland) · Jinyu Bio-Technology (China) |
|
Market Opportunities |
· Integration of digital veterinary surveillance systems · Rising adoption of multivalent and high-potency vaccines · Emerging markets with high livestock populations |
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. |
FMD Vaccine Market Trends
“Growth in global livestock population”
- The sustained growth in Global livestock population is a fundamental driver of the Global Foot and Mouth Disease (FMD) vaccine market, as expanding herds of cattle, buffalo, sheep, and goats significantly increase disease exposure risk and transmission probability across regions. Rising demand for animal protein, coupled with population growth and income improvements in developing economies, has accelerated livestock intensification and large-scale commercial farming systems.
- This structural expansion leads to higher animal density per farm, increased cross-border livestock movement, and greater vulnerability to transboundary animal diseases such as FMD. According to international animal health agencies, FMD remains endemic in several regions and continues to spread into previously unaffected zones, reinforcing the need for preventive vaccination strategies.
- As livestock populations expand, governments are increasingly adopting mass immunization programs to protect food security, reduce economic losses, and stabilize agricultural productivity, thereby directly boosting Global vaccine demand.
- For instance, in March 2025, World Organisation for Animal Health reported that transboundary animal diseases including Foot and Mouth Disease continue to spread across regions, threatening livestock-dependent livelihoods and reinforcing the need for coordinated surveillance and vaccination programs.
- The continuous expansion of Global livestock populations is significantly amplifying the demand for Foot and Mouth Disease vaccines worldwide. Increased herd sizes, intensification of farming systems, and greater animal mobility are collectively heightening disease transmission risks, making preventive vaccination a critical component of national animal health strategies. International organizations consistently emphasize that controlling FMD requires large-scale immunization, especially in endemic regions where livestock density is rising rapidly. As Global meat and dairy demand continues to grow, livestock populations are expected to expand further, ensuring sustained long-term growth in FMD vaccine adoption across both developing and developed markets
FMD Vaccine Market Dynamics
Driver
“Rising prevalence of FMD outbreaks”
- The rising prevalence of Foot and Mouth Disease (FMD) outbreaks across multiple geographies is a critical demand-side driver for the FMD Vaccine Market. Despite decades of control efforts, FMD continues to re-emerge in both endemic and previously disease-free regions, driven by livestock mobility, inadequate vaccination coverage, and porous cross-border animal trade. Increasing outbreak frequency disrupts livestock productivity through reduced milk yield, weight loss, trade restrictions, and high mortality in young animals, compelling governments to rely heavily on preventive vaccination rather than reactive containment.
- The cyclical nature of outbreaks has created sustained demand for emergency vaccine stockpiling and routine immunization programs. Moreover, Globalization of livestock supply chains and climate-related ecological shifts have further intensified viral persistence and transmission. As a result, FMD outbreaks are no longer isolated events but recurring systemic risks, reinforcing long-term vaccine procurement strategies across Asia, Africa, Europe, and parts of South America.
- For instance, in January 2025, Reuters reported that Germany confirmed its first Foot-and-Mouth Disease outbreak in nearly 40 years near Berlin, prompting containment zones, livestock culling, and trade restrictions affecting meat and dairy exports.
- The verified instances demonstrate that Foot-and-Mouth Disease outbreaks have not only re-emerged in previously disease-free regions but have also expanded rapidly across endemic geographies, resulting in large-scale livestock infections, emergency responses, and trade disruptions. Government agencies and international organizations have consistently reported high transmission rates, cross-border risks, and recurring outbreaks, reinforcing the need for sustained vaccination programs. This persistent epidemiological pressure has elevated vaccine demand as a critical preventive tool, thereby acting as a strong structural driver for the growth of the FMD Vaccine Market
Restraint/Challenge
“Limited cold chain infrastructure”
- Limited cold chain infrastructure is a significant restraint in the Global Foot and Mouth Disease (FMD) vaccine market, as many regions particularly in low- and middle-income countries lack the required temperature-controlled logistics systems to ensure vaccine potency from manufacturing to field administration. FMD vaccines are highly temperature sensitive and require strict storage conditions typically between 2°C and 8°C, making uninterrupted refrigeration essential across transportation, warehousing, and rural distribution networks.
- However, frequent power outages, inadequate rural connectivity, insufficient refrigerated transport, and lack of trained personnel often lead to vaccine degradation before administration. This reduces immunization effectiveness and increases the risk of disease persistence even in vaccinated herds. Additionally, fragmented supply chains and weak last mile delivery systems further limit vaccine penetration in remote livestock populations. As a result, cold chain limitations directly constrain vaccination coverage, reduce program efficiency, and act as a major barrier to scaling the FMD Vaccine Market.
- For instance, In January 2025, Reuters reported that Indonesia launched a nationwide Foot-and-Mouth Disease vaccination program across multiple provinces, highlighting logistical challenges in distributing vaccines efficiently across large and geographically dispersed livestock regions
- Limited cold chain infrastructure continues to represent a critical structural restraint in the Global Foot-and-Mouth Disease vaccine market. The strict temperature requirements of FMD vaccines necessitate reliable refrigeration, transport, and storage systems, which remain underdeveloped in many high-risk livestock regions. Infrastructural gaps, geographic dispersion, and logistical inefficiencies contribute to vaccine degradation, reduced immunization effectiveness, and increased operational costs.
- These constraints hinder large-scale vaccination coverage and slow disease control efforts. As Global initiatives intensify toward FMD eradication, addressing cold chain limitations through infrastructure investment and technological integration will be essential. Until such improvements are achieved, cold chain deficiencies will continue to restrict market penetration and limit the overall growth potential of the FMD Vaccine Market
FMD Vaccine Market Scope
The FMD Vaccine Market is categorized into eight notable segments which are based on vaccine type, type, vaccination route, animal type, formulation type, application, distribution channel, end user.
- By Vaccine Type
On the basis of Vaccine Type, FMD Vaccine Market is segmented into Conventional Vaccines, Next-Generation / Advanced Vaccines, Others. The Conventional Vaccines segment is dominated the market with 76.22% market share in 2025, due to their widespread adoption, proven efficacy, and established manufacturing infrastructure. These inactivated vaccines are widely used in government-led mass vaccination programs across endemic regions, as they provide reliable immunity against multiple FMD virus serotypes and are supported by well-developed production and distribution networks. Their cost-effectiveness, regulatory acceptance, and compatibility with large-scale immunization campaigns make them the preferred choice for controlling and preventing FMD outbreaks Globally.
The Next-Generation / Advanced Vaccines segment is anticipated to witness the fastest CAGR of 8.0% from 2026 to 2033, fueled by increasing adoption of innovative technologies such as recombinant and marker vaccines for improved safety and differentiation of infected vs. vaccinated animals (DIVA). Growth is further supported by rising focus on effective control of Foot-and-Mouth Disease, along with advancements in vaccine efficacy, longer immunity duration, and strong government and private sector investments in modern veterinary biologics.
- By Type
On the basis of Type, the FMD Vaccine Market is segmented into Multivalent Vaccines, Monovalent Vaccines. The Multivalent Vaccines segment is dominated the market with market share of 61.20% in 2025, due to its ability to provide protection against multiple virus serotypes within a single formulation. Given the high genetic variability of the FMD virus and the circulation of different strains across regions, multivalent vaccines are widely preferred in large-scale vaccination programs to ensure broader immunity and effective outbreak control. Their role in reducing the need for multiple vaccinations, improving operational efficiency, and supporting comprehensive disease management strategies makes them a critical component in Global FMD prevention effort.
The Monovalent Vaccines segment is anticipated to witness the fastest CAGR of 7.4% from 2026 to 2033, fueled by their targeted effectiveness against specific strains of Foot-and-Mouth Disease, ensuring higher immune response and better outbreak control. Additionally, increasing preference for precision vaccination strategies and improved disease surveillance systems across livestock populations is accelerating their adoption in the GLOBAL region.
- By Vaccination Route
On the basis of Vaccination Route, the FMD Vaccine Market is segmented into Intramuscular, Subcutaneous, Others. The Intramuscular segment is expected to dominated the market with market share of 64.25% in 2025, due to its widespread adoption, scalability, and strong alignment with the growing need for broad-spectrum disease protection. Multivalent FMD vaccines provide immunity against multiple virus serotypes in a single dose, making them highly cost-effective and operationally efficient for large-scale vaccination programs. Their ability to reduce logistical complexity, minimize repeated vaccinations, and ensure comprehensive herd immunity makes them particularly suitable for diverse livestock populations across endemic region.
The subcutaneous segment is anticipated to witness the fastest CAGR of 7.6% from 2026 to 2033, fueled by its ease of administration, reduced risk of complications, and suitability for large-scale livestock vaccination programs. Additionally, its ability to ensure consistent immune response and growing preference among veterinarians for safe and efficient delivery methods are further supporting its rapid adoption.
- By Animal Type
On the basis of Animal Type, FMD Vaccine Market is segmented into Bovine, Porcine, Ovine, Caprine, Others. The Bovine segment is expected to dominated the FMD Vaccine Market share 54.75% in 2025, due to the high susceptibility of cattle to Foot-and-Mouth Disease and their significant economic importance in the Global livestock industry. Cattle represent the largest share of vaccination programs as they are primary contributors to meat and dairy production, making disease prevention critical to ensuring food security and minimizing economic losses.
The Caprine segment is anticipated to witness the fastest CAGR of 7.8% from 2026 to 2033, fueled by the rising population of goats and increasing demand for goat-derived products such as milk, meat, and fiber across developing economies. Additionally, growing awareness about Foot-and-Mouth Disease prevention in small ruminants and expanding government-led vaccination programs are supporting higher adoption of vaccines in the caprine segment.
- By Formulation Type
On the basis of Formulation Type, the FMD Vaccine Market is segmented into Liquid Vaccines, Lyophilized (Freeze-Dried) Vaccines, Others. The Liquid Vaccines segment is expected to dominated the FMD Vaccine market with share of 68.52% in 2025 due to its widespread use, ease of administration, and strong suitability for large-scale vaccination programs. Liquid formulations are preferred for routine immunization as they allow quick deployment, consistent dosing, and efficient coverage of large livestock populations, particularly in endemic regions.
The Lyophilized (Freeze-Dried) Vaccine segment is anticipated to witness the fastest CAGR of 7.6% from 2026 to 2033, fueled by improved thermal stability and longer shelf life, which reduce dependence on stringent cold chain logistics in regions prone to Foot-and-Mouth Disease outbreaks. Additionally, ease of storage, transportation, and rapid reconstitution makes these vaccines highly suitable for large-scale immunization programs across remote and resource-limited areas.
- By Application
On the basis of Application, the FMD Vaccine Market is segmented into Routine Prophylactic Vaccination, Emergency Vaccination (Outbreak Control), Others. The Routine Prophylactic Vaccination segment is expected to dominated the market with market share of 68.39% in 2025, due to its widespread adoption and critical role in preventing disease outbreaks in endemic regions. Regular vaccination programs are widely implemented by governments to maintain herd immunity, reduce transmission risks, and minimize economic losses in the livestock sector.
The Emergency Vaccination (Outbreak Control) segment is anticipated to witness the fastest CAGR of 7.7% from 2026 to 2033, fueled by the rising frequency of Foot-and-Mouth Disease outbreaks and the urgent need for rapid containment measures to minimize economic losses in the livestock sector. Additionally, increasing government preparedness programs, stockpiling of vaccines, and improved disease surveillance systems are accelerating the adoption of emergency vaccination strategies across affected regions.
- By End User
On the basis of End User, the FMD Vaccine Market is segmented into Commercial Livestock Farms, Veterinary Hospitals, Veterinary Care Centers, Vaccination Centers, Others. The Commercial Livestock Farms segment is expected to dominated the market with market share 46.59% in 2025 due to its large-scale operations, strong purchasing cGlobality, and high focus on disease prevention to protect productivity and profitability. These farms manage large livestock populations, making them more vulnerable to rapid disease transmission and economic losses, thereby driving consistent demand for routine vaccination.
The Vaccination Centres segment is anticipated to witness the fastest CAGR of 7.9% from 2026 to 2033, fueled by increasing government-led immunization programs and the expansion of organized veterinary healthcare infrastructure across rural and urban areas. Additionally, rising awareness among livestock owners and improved access to centralized vaccination services are enhancing vaccine coverage and driving segment growth.
- By Distribution Channel
On the basis of Distribution Channel, the FMD Vaccine Market is segmented into Direct Sales (Government Procurement & Tender Supply), Retail Sales, Others. In 2026, the Direct Sales (Government Procurement & Tender Supply) segment is expected to dominated the market with market share of 78.57% in 2025, due to the strong role of governments in organizing and funding large-scale vaccination programs. Public authorities procure vaccines through centralized tenders to ensure widespread coverage, disease control, and outbreak prevention across national livestock populatio.
The Retail Sales segment is anticipated to witness the fastest CAGR of 7.6% from 2026 to 2033, fueled by increasing consumer preference for convenient and direct purchasing channels, along with the rapid expansion of organized retail networks. Growth is further supported by rising urbanization, improved product accessibility, and the growing presence of supermarkets, specialty stores, and e-commerce platforms enhancing product availability and visibility.
FMD Vaccine Market Regional Analysis
- The Asia-Pacific region holds a dominant position in the Foot-and-Mouth Disease (FMD) vaccine market, accounting for 38.99% market share and projected to grow at a CAGR of 7.5% during the forecast period. This leadership is driven by high livestock populations, frequent disease outbreaks, and strong government-led vaccination programs across key countries such as China, India, and South Korea, along with expanding veterinary healthcare infrastructure and increasing focus on food security.
- Emerging economies including Southeast Asia and Australia are contributing steadily to market growth through rising livestock farming, improved disease surveillance systems, and increasing awareness regarding animal health management. Market expansion in these regions is further supported by public-private partnerships, advancements in vaccine production technologies, and growing investments in cold chain logistics, ensuring effective vaccine distribution across rural and semi-urban areas.
Asia-Pacific FMD Market
Asia-Pacific is projected to account for a significant share of the global FMD market in 2025, supported by a large livestock population, increasing incidence of transboundary animal diseases, and rising focus on animal health management. Growth in the region is driven by expanding vaccination programs, government-led disease control initiatives, and growing awareness among farmers regarding livestock productivity and biosecurity. Countries across the region are investing in veterinary healthcare infrastructure, surveillance systems, and advanced vaccine technologies to control outbreaks effectively. Additionally, increasing demand for dairy and meat products further strengthens the need for robust FMD prevention strategies across Asia-Pacific.
China FMD Market Insight
China plays a dominant role in the FMD market due to its large livestock base and strong government involvement in disease control programs. The country has implemented extensive vaccination campaigns and strict monitoring systems to manage FMD outbreaks. Its market is shaped by high demand for vaccines, diagnostic solutions, and veterinary services. In recent years, regulatory measures and biosecurity policies have increased the strategic importance of FMD control, positioning China as a key influencer in regional disease management practices.
India FMD Market Insight
India is witnessing steady growth in the FMD market, driven by large-scale government initiatives such as nationwide vaccination programs and livestock health schemes. Increasing demand for dairy and meat products, coupled with rising awareness of animal health, is supporting market expansion. Additionally, improvements in veterinary infrastructure, disease surveillance, and rural outreach programs are enhancing the adoption of FMD vaccines and diagnostics. Government focus on livestock productivity and disease eradication continues to play a crucial role in strengthening India’s position in the regional market.
North America FMD Market Insight
The North America FMD market is expected to witness steady growth over the forecast period, driven by strong biosecurity frameworks, advanced veterinary healthcare systems, and increasing investments in disease preparedness. Although FMD outbreaks are rare in the region, continuous monitoring, vaccine stockpiling, and emergency response planning contribute to market growth. Rising focus on safeguarding livestock industries and ensuring food security further supports demand for FMD-related solutions.
U.S. FMD Market Insight
The United States FMD market accounted for the largest share within North America in 2025, supported by robust disease surveillance systems, strong research capabilities, and government preparedness programs. Increasing investments in vaccine banks, diagnostic technologies, and rapid response mechanisms are key growth drivers. Additionally, emphasis on protecting livestock exports and maintaining disease-free status further boosts demand for preventive solutions.
Canada FMD Market Insight
The Canada FMD market is expected to grow steadily, supported by strong regulatory frameworks, livestock health management practices, and focus on disease prevention. Canada emphasizes biosecurity, surveillance, and contingency planning to mitigate potential outbreaks. Additionally, increasing collaboration between government agencies and veterinary organizations contributes to the steady development of the FMD market.
Europe FMD Market Insight
The Europe FMD market is projected to grow at a healthy CAGR, driven by stringent animal health regulations, strong veterinary infrastructure, and increasing focus on disease prevention. Investments in advanced diagnostics, vaccine development, and surveillance systems are supporting market growth. Additionally, emphasis on cross-border disease control and livestock safety enhances the adoption of FMD prevention strategies across the region
U.K. FMD Market Insight
The United Kingdom FMD market is expected to register notable growth, supported by strong government policies, advanced veterinary research, and increased focus on biosecurity. The country’s proactive approach toward disease monitoring and outbreak preparedness continues to drive demand for vaccines and diagnostic tools.
Germany FMD Market Insight
The Germany FMD market is anticipated to expand at a considerable CAGR, driven by strong livestock management practices, advanced veterinary technologies, and increasing emphasis on disease prevention. Germany’s leadership in animal health research and regulatory compliance supports the adoption of innovative FMD control solutions. Additionally, integration of advanced diagnostics and vaccination programs reinforces its position as a key market within Europe.
FMD Vaccine Market Share
The FMD Vaccine Market is primarily led by well-established companies, including:
- Boehringer Ingelheim (Germany)
- Ceva Santé Animale (France)
- Biogénesis Bagó (Argentina)
- Indian Immunologicals Ltd. (India)
- China Animal Husbandry Industry Co., Ltd. (CAHIC) (China)
- Zoetis (U.S.)
- Botswana Vaccine Institute (Botswana)
- Brilliant Bio Pharma Ltd. (India)
- Vetal Animal Health (India)
- Vecol S.A. (Colombia)
- Biovet Pvt. Ltd. (India)
- Limor de Colombia (Colombia)
- MEVAC (Egypt)
- Kenya Veterinary Vaccines Production Institute (Kenya)
- Wuhan Institute of Biological Products Co., Ltd. (China)
- Shanghai Shen Lian Biomedical Corporation (China)
- Shchelkovo Biocombinat (Russia)
- Dollvet (Turkey)
- Enimmune Corp. (South Korea)
- National Veterinary Institute (Poland)
- Jinyu Bio-Technology (China)
Latest Developments in FMD Vaccine Market
- In June 2025 company launched a new 3-in-1 poultry vaccine designed to protect against multiple major diseases with a single dose, improving efficiency and bird health in the poultry sector.
- In February 2025, the Launch of advanced genomics lab for vaccines. Ceva inaugurated Biogenovac, a state-of-the-art genomics laboratory focused on developing next-generation vaccines and preventing future animal health crises.
- In March 2026, China Animal Husbandry Industry Co., Ltd. announced plans to acquire stakes in pharmaceutical firms, including a controlling 72.73% stake in Inner Mongolia Shengxue Dacheng Pharmaceutical, marking a strategic expansion from animal health into the broader pharmaceutical sector to strengthen its healthcare portfolio.
- In February 2026 the Participation in Global vaccine forum. Indian Immunological announced participation in the World Vaccine Congress 2026 (Washington), highlighting its ongoing work in animal and human vaccine development.
- In March 2026, the launch of Bioaftogen FMD vaccine in South Africa. Biogénesis Bagó launched its Bioaftogen FMD vaccine in South Africa and secured a government agreement to supply millions of doses to control ongoing outbreaks.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL FMD VACCINE MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 MARKET APPLICATION COVERAGE GRID
2.1 VENDOR SHARE ANALYSIS
2.11 ECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
4.3 EPIDEMIOLOGY OF FOOT-AND-MOUTH DISEASE (FMD)
4.3.1 FMD INCIDENCE RATE BY SPECIES AND REGION
4.3.1.1 INCIDENCE BY SPECIES AND MORBIDITY BURDEN
4.3.1.2 PREVALENCE PATTERNS AND REGIONAL SEROTYPE DISTRIBUTION
4.3.2 VACCINATION COVERAGE RATE
4.4 MORTALITY AND MORBIDITY IMPACT
4.4.1 VACCINE COMPLIANCE AND PROGRAM ADHERENCE
4.4.2 DISEASE CONTAINMENT SUCCESS RATES
4.5 INDUSTRY INSIGHTS
4.5.1 MICRO AND MACRO ECONOMIC FACTORS
4.5.2 PENETRATION AND GROWTH PROSPECT MAPPING
4.5.3 KEY PRICING STRATEGIES
4.5.4 INTERVIEWS WITH SPECIALISTS
4.5.5 ANALYSIS AND RECOMMENDATION
4.6 COMPANY EVALUATION QUADRANT
4.7 DISTRIBUTION OF PRODUCTS AND PROJECTS BY PHASE GLOBAL FMD VACCINE MARKET
4.8 DISTRIBUTION OF PROJECTS BY SCIENTIFIC APPROACH AND PHASE GLOBAL FMD VACCINE MARKET
4.9 DISTRIBUTION OF PROJECTS BY SPECIES AND PHASE GLOBAL FMD VACCINE MARKET
4.1 GLOBAL CLINICAL TRIAL MARKET FOR GLOBAL FMD VACCINE MARKET
4.11 HEALTHCARE TARIFFS IMPACT ANALYSIS
4.11.1 OVERVIEW
4.11.2 TARIFF STRUCTURES
4.11.2.1 GLOBAL VS. REGIONAL TARIFF STRUCTURES
4.11.2.2 UNITED STATES: USDA/APHIS TARIFF POLICIES, ANIMAL HEALTH PROGRAM MODELS
4.11.2.2.1 EUROPEAN UNION: CROSS-BORDER TRADE REGULATIONS, SUBSIDY POLICIES
4.11.2.2.2 ASIA-PACIFIC: IMPORT AND EXPORT CONTROLS ON VETERINARY VACCINES
4.11.2.2.3 EMERGING MARKETS: CHALLENGES IN TARIFF IMPLEMENTATION
4.11.3 PHARMACEUTICAL (VETERINARY BIOLOGICS) TARIFFS AND TRADE BARRIERS
4.11.3.1 IMPORT DUTIES ON VACCINES AND BIOLOGICALS
4.11.3.2 IMPACT ON AFFORDABILITY AND ACCESS IN RURAL AREAS
4.11.3.3 KEY TRADE AGREEMENTS AFFECTING ANIMAL HEALTH PRODUCT TARIFFS
4.11.4 IMPACT OF HEALTHCARE TARIFFS ON PROVIDERS AND FARMERS
4.11.4.1 COST BURDEN ON COMMERCIAL FARMS AND VETERINARIANS
4.11.4.2 EFFECT ON VACCINE AFFORDABILITY AND HERD COVERAGE
4.11.4.3 TARIFFS AND IMPACT ON ANIMAL TRADE/MOVEMENT
4.11.5 TRADE AGREEMENTS AND ANIMAL HEALTH TARIFFS
4.11.5.1 WTO REGULATIONS ON VETERINARY PRODUCTS
4.11.5.2 IMPACT OF TRADE WARS ON VACCINE SUPPLY CHAIN
4.11.5.3 ROLE OF FREE TRADE AGREEMENTS (FTAS) IN TARIFF REDUCTION
4.11.6 IMPACT OF TARIFFS ON VETERINARY VACCINE COSTS & ACCESSIBILITY
4.11.7 IMPORTANCE OF TARIFFS IN THE ANIMAL HEALTH SECTOR
4.12 MARKETED VACCINE ANALYSIS
4.12.1 VACCINE BRAND & GENERIC NAME / ANTIGENIC STRAIN
4.12.2 INDICATION
4.12.3 PHARMACOLOGICAL CLASS OF THE VACCINE
4.12.4 PRIMARY INDICATION
4.12.5 MARKET STATUS
4.12.6 VACCINE TYPE (CONVENTIONAL, NEXT-GEN, ETC.)
4.12.7 DOSAGE FORM
4.12.8 DOSAGE AVAILABILITY
4.12.9 PACKAGING TYPE
4.12.10 ROUTE OF ADMINISTRATION
4.12.11 DOSING FREQUENCY
4.12.12 VACCINE INSIGHT
4.12.13 OVERVIEW OF DEVELOPMENT ACTIVITIES (APPROVALS, SAFETY, EFFICACY, MARKET EXCLUSIVITY)
4.12.13.1 FORECAST MARKET OUTLOOK
4.12.14 CROSS COMPETITION (BY STRAIN/VALENCY)
4.12.15 THERAPEUTIC PORTFOLIO
4.12.16 CURRENT DEVELOPMENT SCENARIO
4.13 PATENT ANALYSIS
4.13.1 PATENT QUALITY AND STRENGTH
4.13.2 COUNTRY PATENT LANDSCAPE
4.13.3 IP STRATEGY AND MANAGEMENT
4.13.4 LICENSING AND COLLABORATION
4.14 TOP ENTITIES BASED ON R&D GLANCE FOR GLOBAL FMD VACCINE MARKET
4.15 MARKET ACCESS
4.15.1 10-YEAR MARKET FORECAST
4.15.2 CLINICAL TRIAL RECENT UPDATES
4.15.3 ANNUAL NEW VACCINE APPROVALS (OIE/REGIONAL AUTHORITIES)
4.15.4 LEADING MANUFACTURERS AND STRATEGIC DEALS
4.15.5 MAJOR VACCINE UPTAKE
4.15.6 CURRENT VACCINATION PRACTICES
4.15.7 IMPACT OF UPCOMING TECHNOLOGIES AND THERAPY
4.16 R & D ANALYSIS
4.16.1 COMPARATIVE ANALYSIS
4.16.2 VACCINE DEVELOPMENT LANDSCAPE
4.16.3 IN-DEPTH INSIGHTS ON REGULATORY MILESTONES
4.16.4 THERAPEUTIC ASSESSMENT
4.16.5 ASSET-BASED COLLABORATIONS AND PARTNERSHIPS
5 WAR-DRIVEN DISRUPTION IN VETERINARY VACCINE SUPPLY CHAINS, GEOGRAPHIC FOOTPRINTS, STRUCTURAL CHANGES, AND ADAPTIVE STRATEGIES
5.1 SUPPLY CHAIN RESILIENCE
5.1.1 DIVERSIFICATION OF ANTIGEN AND ADJUVANT INGREDIENT SUPPLIERS
5.1.2 ESTABLISHMENT OF REGIONAL VETERINARY VACCINE MANUFACTURING HUBS
5.1.3 STRATEGIC STOCKPILING OF EMERGENCY VACCINE BANKS
5.1.4 DEVELOPMENT OF ALTERNATIVE COLD CHAIN LOGISTICS ROUTES
5.1.5 STRATEGIC PARTNERSHIPS WITH CONTRACT MANUFACTURERS (CDMOS)
5.1.6 EXPANSION OF VACCINE FILL-FINISH AND PACKAGING CAPACITIES
5.2 ENERGY & MANUFACTURING OPERATIONAL COST RISK
5.2.1 RISING ENERGY COSTS IN ANIMAL HEALTH PRODUCTION FACILITIES
5.2.2 INCREASED COSTS FOR BIOLOGICS RAW MATERIALS AND COMPONENTS
5.2.3 LONG-TERM ENERGY PROCUREMENT STRATEGIES FOR VETERINARY PLANTS
5.2.4 ADOPTION OF ENERGY-EFFICIENT BIOPHARMA MANUFACTURING TECHNOLOGIES
5.2.5 DEPLOYMENT OF ADVANCED AUTOMATION AND CONTINUOUS MANUFACTURING
5.2.6 INTEGRATION OF RENEWABLE ENERGY IN VETERINARY VACCINE PLANTS
5.3 GEOGRAPHIC FOOTPRINT REASSESSMENT
5.3.1 EXPANSION OF VACCINE PRODUCTION IN POLITICALLY STABLE REGIONS
5.3.2 DIVERSIFICATION OF GLOBAL VETERINARY VACCINE BASES
5.3.3 RELOCATION OF ANTIGEN PRODUCTION FACILITIES
5.3.4 EXPANSION OF MANUFACTURING IN EMERGING ANIMAL HEALTH MARKETS
5.3.5 ESTABLISHMENT OF REGIONAL VETERINARY VACCINE DISTRIBUTION HUBS
5.4 SCENARIO PLANNING & RISK MANAGEMENT
5.4.1 DEVELOPMENT OF SUPPLY CHAIN CONTINGENCY PLANS FOR OUTBREAKS
5.4.2 MULTI-SOURCE PROCUREMENT STRATEGIES FOR KEY VACCINE INGREDIENTS
5.4.3 GOVERNMENT AND ANIMAL HEALTH AUTHORITY COLLABORATIONS
5.4.4 CRISIS-RESPONSE VACCINE DEPLOYMENT NETWORKS
5.4.5 DEPLOYMENT OF SUPPLY CHAIN ANALYTICS IN VACCINE DISTRIBUTION
5.5 CASH & FINANCIAL PROTECTION
5.5.1 STRENGTHENING CAPITAL RESERVES FOR MANUFACTURING EXPANSION
5.5.2 DIVERSIFICATION OF PRODUCT PORTFOLIOS AND REVENUE STREAMS
5.5.3 INVESTMENTS IN DOMESTIC VACCINE MANUFACTURING INFRASTRUCTURE
5.5.4 GOVERNMENT INCENTIVES FOR ANIMAL HEALTH PRODUCTION
5.5.5 LONG-TERM PROCUREMENT AGREEMENTS WITH GOVERNMENTS AND ORGANIZATIONS
5.6 DATA PROTECTION
5.6.1 DATA PROTECTION FRAMEWORKS FOR ANIMAL HEALTH R&D AND MANUFACTURING
5.6.2 PROTECTION OF VETERINARY CLINICAL TRIAL AND FIELD DATA
5.6.3 SECURE CLOUD INFRASTRUCTURE FOR VACCINE DATA MANAGEMENT
5.6.4 AI-DRIVEN THREAT DETECTION IN RESEARCH AND SUPPLY NETWORKS
5.6.5 COMPLIANCE WITH GLOBAL ANIMAL HEALTH DATA REGULATIONS AND GXP STANDARDS
6 REGULATORY FRAMEWORK FOR FMD VACCINES
6.1 REGULATORY APPROVAL PROCESS FOR FMD VACCINES
6.1.1 INTERNATIONAL NORMS AND STANDARDS FOR FMD VACCINES
6.1.2 BIOSAFETY AND CONTAINMENT REGULATIONS
6.2 GEOGRAPHIES’ EASE OF REGULATORY APPROVAL
6.3 REGULATORY APPROVAL PATHWAYS FOR VETERINARY VACCINES
6.4 LICENSING AND REGISTRATION REQUIREMENTS
6.5 POST-MARKETING SURVEILLANCE FOR VETERINARY PRODUCTS
6.6 GOOD MANUFACTURING PRACTICES (GMP) GUIDELINES FOR ANIMAL HEALTH
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 GROWTH IN GLOBAL LIVESTOCK POPULATION
7.1.2 RISING PREVALENCE OF FMD OUTBREAKS
7.1.3 GROWING GOVERNMENT VACCINATION PROGRAMS
7.1.4 INCREASING AWARENESS OF ANIMAL HEALTH AND BIOSECURITY
7.2 RESTRAINTS
7.2.1 LIMITED COLD CHAIN INFRASTRUCTURE
7.2.2 VACCINE HESITANCY AND FIELD CHALLENGES
7.3 OPPORTUNITIES
7.3.1 INTEGRATION OF DIGITAL VETERINARY SURVEILLANCE SYSTEMS
7.3.2 RISING ADOPTION OF MULTIVALENT AND HIGH-POTENCY VACCINES
7.3.3 EMERGING MARKETS WITH HIGH LIVESTOCK POPULATIONS
7.4 CHALLENGES
7.4.1 VIRAL MUTATION AND SEROTYPE VARIABILITY
7.4.2 ENFORCEMENT OF VACCINATION REGULATIONS
8 GLOBAL FMD VACCINE MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 CONVENTIONAL VACCINES
8.3 NEXT-GENERATION / ADVANCED VACCINES
8.4 OTHERS
8.5 GLOBAL FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
8.5.1 CONVENTIONAL VACCINES
8.5.2 NEXT-GENERATION / ADVANCED VACCINES
8.5.3 OTHERS
9 GLOBAL FMD VACCINE MARKET, BY TYPE
9.1 OVERVIEW
9.2 INACTIVATED (KILLED) VACCINES
9.3 LIVE ATTENUATED VACCINES
9.4 GLOBAL CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.4.1 ASIA-PACIFIC
9.4.2 EUROPE
9.4.3 NORTH AMERICA
9.4.4 SOUTH AMERICA
9.4.5 MIDDLE EAST AND AFRICA
9.5 GLOBAL NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.5.1 RECOMBINANT VECTOR-BASED VACCINES
9.5.2 VIRUS-LIKE PARTICLE (VLP) VACCINES
9.5.3 SUBUNIT VACCINES
9.5.4 OTHERS
9.6 GLOBAL CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.6.1 ASIA-PACIFIC
9.6.2 EUROPE
9.6.3 NORTH AMERICA
9.6.4 SOUTH AMERICA
9.6.5 MIDDLE EAST AND AFRICA
9.7 GLOBAL OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.7.1 ASIA-PACIFIC
9.7.2 EUROPE
9.7.3 NORTH AMERICA
9.7.4 SOUTH AMERICA
9.7.5 MIDDLE EAST AND AFRICA
9.8 GLOBAL FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.8.1 MULTIVALENT VACCINES
9.8.2 MONOVALENT VACCINES
9.9 GLOBAL MULTIVALENT VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.9.1 ASIA-PACIFIC
9.9.2 EUROPE
9.9.3 NORTH AMERICA
9.9.4 SOUTH AMERICA
9.9.5 MIDDLE EAST AND AFRICA
9.1 GLOBAL MONOVALENT VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.10.1 ASIA-PACIFIC
9.10.2 EUROPE
9.10.3 NORTH AMERICA
9.10.4 SOUTH AMERICA
9.10.5 MIDDLE EAST AND AFRICA
10 GLOBAL FMD VACCINE MARKET, BY VACCINATION ROUTE
10.1 OVERVIEW
10.2 INTRAMUSCULAR
10.3 SUBCUTANEOUS
10.4 OTHERS
10.5 GLOBAL INTRAMUSCULAR IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
10.5.1 ASIA-PACIFIC
10.5.2 EUROPE
10.5.3 NORTH AMERICA
10.5.4 SOUTH AMERICA
10.5.5 MIDDLE EAST AND AFRICA
10.6 GLOBAL SUBCUTANEOUS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
10.6.1 ASIA-PACIFIC
10.6.2 EUROPE
10.6.3 NORTH AMERICA
10.6.4 SOUTH AMERICA
10.6.5 MIDDLE EAST AND AFRICA
10.7 GLOBAL OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
10.7.1 ASIA-PACIFIC
10.7.2 EUROPE
10.7.3 NORTH AMERICA
10.7.4 SOUTH AMERICA
10.7.5 MIDDLE EAST AND AFRICA
11 GLOBAL FMD VACCINE MARKET, BY ANIMAL TYPE
11.1 OVERVIEW
11.2 BOVINE
11.3 PORCINE
11.4 OVINE
11.5 CAPRINE
11.6 OTHERS
11.7 GLOBAL BOVINE IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
11.7.1 ASIA-PACIFIC
11.7.2 EUROPE
11.7.3 NORTH AMERICA
11.7.4 SOUTH AMERICA
11.7.5 MIDDLE EAST AND AFRICA
11.8 GLOBAL PORCINE IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
11.8.1 ASIA-PACIFIC
11.8.2 EUROPE
11.8.3 NORTH AMERICA
11.8.4 SOUTH AMERICA
11.8.5 MIDDLE EAST AND AFRICA
11.9 GLOBAL OVINE IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
11.9.1 ASIA-PACIFIC
11.9.2 EUROPE
11.9.3 NORTH AMERICA
11.9.4 SOUTH AMERICA
11.9.5 MIDDLE EAST AND AFRICA
11.1 GLOBAL CAPRINE IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
11.10.1 ASIA-PACIFIC
11.10.2 EUROPE
11.10.3 NORTH AMERICA
11.10.4 SOUTH AMERICA
11.10.5 MIDDLE EAST AND AFRICA
11.11 GLOBAL OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
11.11.1 ASIA-PACIFIC
11.11.2 EUROPE
11.11.3 NORTH AMERICA
11.11.4 SOUTH AMERICA
11.11.5 MIDDLE EAST AND AFRICA
12 GLOBAL FMD VACCINE MARKET, BY FORMULATION TYPE
12.1 OVERVIEW
12.2 LIQUID VACCINES
12.3 LYOPHILIZED (FREEZE-DRIED) VACCINES
12.4 OTHERS
12.5 GLOBAL LIQUID VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.5.1 ASIA-PACIFIC
12.5.2 EUROPE
12.5.3 NORTH AMERICA
12.5.4 SOUTH AMERICA
12.5.5 MIDDLE EAST AND AFRICA
12.6 GLOBAL LYOPHILIZED (FREEZE-DRIED) VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.6.1 ASIA-PACIFIC
12.6.2 EUROPE
12.6.3 NORTH AMERICA
12.6.4 SOUTH AMERICA
12.6.5 MIDDLE EAST AND AFRICA
12.7 GLOBAL OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.7.1 ASIA-PACIFIC
12.7.2 EUROPE
12.7.3 NORTH AMERICA
12.7.4 SOUTH AMERICA
12.7.5 MIDDLE EAST AND AFRICA
13 GLOBAL FMD VACCINE MARKET, BY APPLICATION
13.1 OVERVIEW
13.2 ROUTINE PROPHYLACTIC VACCINATION
13.3 EMERGENCY VACCINATION (OUTBREAK CONTROL)
13.4 OTHERS
13.5 GLOBAL ROUTINE PROPHYLACTIC VACCINATION IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
13.5.1 ASIA-PACIFIC
13.5.2 EUROPE
13.5.3 NORTH AMERICA
13.5.4 SOUTH AMERICA
13.5.5 MIDDLE EAST AND AFRICA
13.6 GLOBAL EMERGENCY VACCINATION (OUTBREAK CONTROL) IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
13.6.1 ASIA-PACIFIC
13.6.2 EUROPE
13.6.3 NORTH AMERICA
13.6.4 SOUTH AMERICA
13.6.5 MIDDLE EAST AND AFRICA
13.7 GLOBAL OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
13.7.1 ASIA-PACIFIC
13.7.2 EUROPE
13.7.3 NORTH AMERICA
13.7.4 SOUTH AMERICA
13.7.5 MIDDLE EAST AND AFRICA
14 GLOBAL FMD VACCINE MARKET, BY END USER
14.1 OVERVIEW
14.2 COMMERCIAL LIVESTOCK FARMS
14.3 VETERINARY HOSPITALS
14.4 VETERINARY CARE CENTERS
14.5 VACCINATION CENTRES
14.6 OTHERS
14.7 GLOBAL COMMERCIAL LIVESTOCK FARMS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.7.1 ASIA-PACIFIC
14.7.2 EUROPE
14.7.3 NORTH AMERICA
14.7.4 SOUTH AMERICA
14.7.5 MIDDLE EAST AND AFRICA
14.8 GLOBAL VETERINARY HOSPITALS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.8.1 ASIA-PACIFIC
14.8.2 EUROPE
14.8.3 NORTH AMERICA
14.8.4 SOUTH AMERICA
14.8.5 MIDDLE EAST AND AFRICA
14.9 GLOBAL VETERINARY CARE CENTERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.9.1 ASIA-PACIFIC
14.9.2 EUROPE
14.9.3 NORTH AMERICA
14.9.4 SOUTH AMERICA
14.9.5 MIDDLE EAST AND AFRICA
14.1 GLOBAL VACCINATION CENTRES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.10.1 ASIA-PACIFIC
14.10.2 EUROPE
14.10.3 NORTH AMERICA
14.10.4 SOUTH AMERICA
14.10.5 MIDDLE EAST AND AFRICA
14.11 GLOBAL OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.11.1 ASIA-PACIFIC
14.11.2 EUROPE
14.11.3 NORTH AMERICA
14.11.4 SOUTH AMERICA
14.11.5 MIDDLE EAST AND AFRICA
15 GLOBAL FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL
15.1 OVERVIEW
15.2 DIRECT SALES (GOVERNMENT PROCUREMENT & TENDER SUPPLY)
15.3 RETAIL SALES
15.4 OTHERS
15.5 GLOBAL DIRECT SALES (GOVERNMENT PROCUREMENT & TENDER SUPPLY) IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
15.5.1 ASIA-PACIFIC
15.5.2 EUROPE
15.5.3 NORTH AMERICA
15.5.4 SOUTH AMERICA
15.5.5 MIDDLE EAST AND AFRICA
15.6 GLOBAL RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
15.6.1 HOSPITAL PHARMACY
15.6.2 RETAIL PHARMACY
15.6.3 ONLINE PHARMACY
15.7 GLOBAL RETAIL SALES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
15.7.1 ASIA-PACIFIC
15.7.2 EUROPE
15.7.3 NORTH AMERICA
15.7.4 SOUTH AMERICA
15.7.5 MIDDLE EAST AND AFRICA
15.8 GLOBAL OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
15.8.1 ASIA-PACIFIC
15.8.2 EUROPE
15.8.3 NORTH AMERICA
15.8.4 SOUTH AMERICA
15.8.5 MIDDLE EAST AND AFRICA
16 GLOBAL FMD VACCINE MARKET, BY REGION
16.1 OVERVIEW
16.2 ASIA PACIFIC
16.2.1 INDIA
16.2.2 CHINA
16.2.3 INDONESIA
16.2.4 THAILAND
16.2.5 MALAYSIA
16.2.6 SOUTH KOREA
16.2.7 TAIWAN
16.2.8 HONG KONG
16.2.9 REST OF APAC
16.3 EUROPE
16.3.1 TURKEY
16.3.2 RUSSIA
16.3.3 GERMANY
16.3.4 FRANCE
16.3.5 U.K.
16.3.6 ITALY
16.3.7 SPAIN
16.3.8 NETHERLANDS
16.3.9 BELGIUM
16.3.10 SWITZERLAND
16.3.11 SWEDEN
16.3.12 NORWAY
16.3.13 DENMARK
16.3.14 FINLAND
16.3.15 REST OF EUROPE
16.4 NORTH AMERICA
16.4.1 U.S.
16.4.2 MEXICO
16.4.3 CANADA
16.5 SOUTH AMERICA
16.5.1 ARGENTINA
16.5.2 COLOMBIA
16.5.3 VENEZUELA
16.5.4 PARAGUAY
16.5.5 ECUADOR
16.5.6 BOLIVIA
16.5.7 PERU
16.5.8 BRAZIL
16.5.9 URUGUAY
16.5.10 CHILE
16.5.11 REST OF SOUTH AMERICA
16.6 MIDDLE EAST AND AFRICA
16.6.1 SOUTH AFRICA
16.6.2 EGYPT
16.6.3 SAUDI ARABIA
16.6.4 ISRAEL
16.6.5 UAE
16.6.6 KUWAIT
16.6.7 OMAN
16.6.8 QATAR
16.6.9 BAHRAIN
16.6.10 REST OF MEA
17 GLOBAL FMD VACCINE MARKET: COMPANY LANDSCAPE
17.1 COMPANY SHARE ANALYSIS: GLOBAL
17.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
17.3 COMPANY SHARE ANALYSIS: EUROPE
17.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
18 SWOT ANALYSIS
19 COMPANY PROFILES
19.1 BOEHRINGER INGELHEIM INTERNATIONAL GMBH.
19.1.1 COMPANY SNAPSHOT
19.1.2 COMPANY SHARE ANALYSIS
19.1.3 PRODUCT PORTFOLIO
19.1.4 RECENT DEVELOPMENT
19.2 CEVA SANTÉ ANIMALE
19.2.1 COMPANY SNAPSHOT
19.2.2 COMPANY SHARE ANALYSIS
19.2.3 PRODUCT PORTFOLIO
19.2.4 RECENT DEVELOPMENT
19.3 CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.
19.3.1 COMPANY SNAPSHOT
19.3.2 REVENUE ANALYSIS
19.3.3 COMPANY SHARE ANALYSIS
19.3.4 PRODUCT PORTFOLIO
19.3.5 RECENT DEVELOPMENT
19.4 INDIAN IMMUNOLOGICALS LTD.
19.4.1 COMPANY SNAPSHOT
19.4.2 COMPANY SHARE ANALYSIS
19.4.3 PRODUCT PORTFOLIO
19.4.4 RECENT DEVELOPMENT
19.5 BIOGÉNESIS BAGÓ
19.5.1 COMPANY SNAPSHOT
19.5.2 COMPANY SHARE ANALYSIS
19.5.3 PRODUCT PORTFOLIO
19.5.4 RECENT DEVELOPMENT
19.6 BIOVET PRIVATE LTD
19.6.1 COMPANY SNAPSHOT
19.6.2 PRODUCT PORTFOLIO
19.6.3 RECENT DEVELOPMENT
19.7 BRILLIANT BIO PHARMA
19.7.1 COMPANY SNAPSHOT
19.7.2 PRODUCT PORTFOLIO
19.7.3 RECENT DEVELOPMENT
19.8 DOLLVET
19.8.1 COMPANY SNAPSHOT
19.8.2 PRODUCT PORTFOLIO
19.8.3 RECENT DEVELOPMENT
19.9 ENIMMUNE CORP.
19.9.1 COMPANY SNAPSHOT
19.9.2 REVENUE ANALYSIS
19.9.3 PRODUCT PORTFOLIO
19.9.4 RECENT DEVELOPMENT
19.1 JINYU BIOTECHNOLOGY CO., LTD.
19.10.1 COMPANY SNAPSHOT
19.10.2 REVENUE ANALYSIS
19.10.3 PRODUCT PORTFOLIO
19.10.4 RECENT DEVELOPMENT
19.11 KENYA VETERINARY VACCINES PRODUCTION INSTITUTE
19.11.1 COMPANY SNAPSHOT
19.11.2 PRODUCT PORTFOLIO
19.11.3 RECENT DEVELOPMENT
19.12 LIMOR DE COLOMBIA SAS
19.12.1 COMPANY SNAPSHOT
19.12.2 PRODUCT PORTFOLIO
19.12.3 RECENT DEVELOPMENT
19.13 MEVAC FOR VACCINES
19.13.1 COMPANY SNAPSHOT
19.13.2 PRODUCT PORTFOLIO
19.13.3 RECENT DEVELOPMENT
19.14 NATIONAL VETERINARY INSTITUTE
19.14.1 COMPANY SNAPSHOT
19.14.2 PRODUCT PORTFOLIO
19.14.3 RECENT DEVELOPMENT
19.15 SHCHELKOVO BIOCOMBINAT
19.15.1 COMPANY SNAPSHOT
19.15.2 PRODUCT PORTFOLIO
19.15.3 RECENT DEVELOPMENT
19.16 SHANGHAI SHEN LIAN BIOMEDICAL CORPORATION
19.16.1 COMPANY SNAPSHOT
19.16.2 REVENUE ANALYSIS
19.16.3 PRODUCT PORTFOLIO
19.16.4 RECENT DEVELOPMENT
19.17 VETAL S.A.
19.17.1 COMPANY SNAPSHOT
19.17.2 PRODUCT PORTFOLIO
19.17.3 RECENT DEVELOPMENT
19.18 VECOL
19.18.1 COMPANY SNAPSHOT
19.18.2 PRODUCT PORTFOLIO
19.18.3 RECENT DEVELOPMENT
19.19 WUHAN INSTITUTE OF BIOLOGICAL PRODUCTS CO., LTD.
19.19.1 COMPANY SNAPSHOT
19.19.2 PRODUCT PORTFOLIO
19.19.3 RECENT DEVELOPMENT
19.2 ZOETIS SERVICES LLC
19.20.1 COMPANY SNAPSHOT
19.20.2 REVENUE ANALYSIS
19.20.3 PRODUCT PORTFOLIO
19.20.4 RECENT DEVELOPMENT
20 QUESTIONNAIRE
21 RELATED REPORTS
List of Table
TABLE 1 GLOBAL FMD VACCINE PRICING STRUCTURE
TABLE 2 FMD SEROTYPE PREVALENCE BY REGION
TABLE 3 ECONOMIC IMPACT OF FMD OUTBREAKS
TABLE 4 MANUFACTURER POSITIONING MAP
TABLE 5 FMD INCIDENCE, MORBIDITY, AND EPIDEMIOLOGICAL RATES
TABLE 6 FMD SEROTYPE PREVALENCE BY REGION
TABLE 7 DISTRIBUTION OF PRODUCTS AND PROJECTS BY PHASE GLOBAL FMD VACCINE MARKET
TABLE 8 DISTRIBUTION OF PROJECTS BY SCIENTIFIC APPROACH AND PHASE GLOBAL FMD VACCINE MARKET
TABLE 9 DISTRIBUTION OF PROJECTS BY SPECIES AND PHASE GLOBAL FMD VACCINE MARKET
TABLE 10 GLOBAL CLINICAL TRIAL MARKET FOR GLOBAL FMD VACCINE MARKET
TABLE 11 DOSAGE FORM CHARACTERISTICS OF FMD VACCINES
TABLE 12 DOSAGE AVAILABILITY OF MARKETED FMD VACCINES
TABLE 13 THERAPEUTIC PORTFOLIO DIVERSIFICATION IN FMD VACCINES
TABLE 14 GLOBAL FMD VACCINE MARKET, BY VACCINE TYPE, 2025
TABLE 15 GLOBAL FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 16 GLOBAL FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 17 GLOBAL CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2025
TABLE 18 GLOBAL CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 19 GLOBAL NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 20 GLOBAL CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 21 GLOBAL OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 22 GLOBAL FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 23 GLOBAL MULTIVALENT VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 24 GLOBAL MONOVALENT VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 25 GLOBAL FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 26 GLOBAL INTRAMUSCULAR IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 27 GLOBAL SUBCUTANEOUS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 28 GLOBAL OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 29 GLOBAL FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 30 GLOBAL BOVINE IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 31 GLOBAL PORCINE IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 32 GLOBAL OVINE IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 33 GLOBAL CAPRINE IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 34 GLOBAL OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 35 GLOBAL FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 36 GLOBAL LIQUID VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 37 GLOBAL LYOPHILIZED (FREEZE-DRIED) VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 38 GLOBAL OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 39 GLOBAL FMD VACCINE MARKET, BY APPLICATION, 2025
TABLE 40 GLOBAL ROUTINE PROPHYLACTIC VACCINATION IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 41 GLOBAL EMERGENCY VACCINATION (OUTBREAK CONTROL) IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 42 GLOBAL OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 43 GLOBAL FMD VACCINE MARKET, BY END USER, 2025
TABLE 44 GLOBAL COMMERCIAL LIVESTOCK FARMS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 45 GLOBAL VETERINARY HOSPITALS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 46 GLOBAL VETERINARY CARE CENTERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 47 GLOBAL VACCINATION CENTRES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 48 GLOBAL OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 49 GLOBAL FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2025
TABLE 50 GLOBAL DIRECT SALES (GOVERNMENT PROCUREMENT & TENDER SUPPLY) IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 51 GLOBAL RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 52 GLOBAL RETAIL SALES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 53 GLOBAL OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 54 GLOBAL FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 55 GLOBAL FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 56 GLOBAL FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 57 GLOBAL FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 58 GLOBAL CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 59 GLOBAL CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 60 GLOBAL NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 61 GLOBAL CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 62 GLOBAL OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 63 GLOBAL FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 64 GLOBAL MULTIVALENT VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 65 GLOBAL MONOVALENT VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 66 GLOBAL FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 67 GLOBAL INTRAMUSCULAR IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 68 GLOBAL SUBCUTANEOUS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 69 GLOBAL OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 70 GLOBAL FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 71 GLOBAL BOVINE IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 72 GLOBAL PORCINE IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 73 GLOBAL OVINE IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 74 GLOBAL CAPRINE IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 75 GLOBAL OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 76 GLOBAL FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 77 GLOBAL LIQUID VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 78 GLOBAL LYOPHILIZED (FREEZE-DRIED) VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 79 GLOBAL OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 80 GLOBAL FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 81 GLOBAL ROUTINE PROPHYLACTIC VACCINATION IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 82 GLOBAL EMERGENCY VACCINATION (OUTBREAK CONTROL) IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 83 GLOBAL OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 84 GLOBAL FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 85 GLOBAL COMMERCIAL LIVESTOCK FARMS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 86 GLOBAL VETERINARY HOSPITALS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 87 GLOBAL VETERINARY CARE CENTERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 88 GLOBAL VACCINATION CENTRES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 89 GLOBAL OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 90 GLOBAL FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 91 GLOBAL DIRECT SALES (GOVERNMENT PROCUREMENT & TENDER SUPPLY) IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 92 GLOBAL RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 93 GLOBAL RETAIL SALES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 94 GLOBAL OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 95 ASIA-PACIFIC FMD VACCINE MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)
TABLE 96 ASIA-PACIFIC FMD VACCINE MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)
TABLE 97 ASIA-PACIFIC
TABLE 98 ASIA-PACIFIC FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 99 ASIA-PACIFIC FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 100 ASIA-PACIFIC FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 101 ASIA-PACIFIC CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 102 ASIA-PACIFIC NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 103 ASIA-PACIFIC FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 104 ASIA-PACIFIC FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 105 ASIA-PACIFIC FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 106 ASIA-PACIFIC FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 107 ASIA-PACIFIC FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 108 ASIA-PACIFIC FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 109 ASIA-PACIFIC FMD VACCINE MARKET, BYDISTRIBUTION CHANNEL , 2018-2033 (USD THOUSAND)
TABLE 110 ASIA-PACIFIC RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 111 INDIA
TABLE 112 INDIA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 113 INDIA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 114 INDIA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 115 INDIA CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 116 INDIA NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 117 INDIA FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 118 INDIA FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 119 INDIA FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 120 INDIA FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 121 INDIA FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 122 INDIA FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 123 INDIA FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL , 2018-2033 (USD THOUSAND)
TABLE 124 INDIA RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 125 CHINA
TABLE 126 CHINA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 127 CHINA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 128 CHINA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 129 CHINA CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 130 CHINA NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 131 CHINA FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 132 CHINA FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 133 CHINA FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 134 CHINA FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 135 CHINA FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 136 CHINA FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 137 CHINA FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL , 2018-2033 (USD THOUSAND)
TABLE 138 CHINA RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 139 INDONESIA
TABLE 140 INDONESIA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 141 INDONESIA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 142 INDONESIA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 143 INDONESIA CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 144 INDONESIA NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 145 INDONESIA FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 146 INDONESIA FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 147 INDONESIA FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 148 INDONESIA FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 149 INDONESIA FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 150 INDONESIA FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 151 INDONESIA FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL , 2018-2033 (USD THOUSAND)
TABLE 152 INDONESIA RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 153 THAILAND
TABLE 154 THAILAND FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 155 THAILAND FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 156 THAILAND FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 157 THAILAND CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 158 THAILAND NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 159 THAILAND FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 160 THAILAND FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 161 THAILAND FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 162 THAILAND FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 163 THAILAND FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 164 THAILAND FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 165 THAILAND FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL , 2018-2033 (USD THOUSAND)
TABLE 166 THAILAND RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 167 MALAYSIA
TABLE 168 MALAYSIA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 169 MALAYSIA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 170 MALAYSIA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 171 MALAYSIA CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 172 MALAYSIA NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 173 MALAYSIA FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 174 MALAYSIA FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 175 MALAYSIA FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 176 MALAYSIA FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 177 MALAYSIA FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 178 MALAYSIA FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 179 MALAYSIA FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL , 2018-2033 (USD THOUSAND)
TABLE 180 MALAYSIA RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 181 SOUTH KOREA
TABLE 182 SOUTH KOREA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 183 SOUTH KOREA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 184 SOUTH KOREA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 185 SOUTH KOREA CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 186 SOUTH KOREA NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 187 SOUTH KOREA FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 188 SOUTH KOREA FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 189 SOUTH KOREA FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 190 SOUTH KOREA FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 191 SOUTH KOREA FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 192 SOUTH KOREA FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 193 SOUTH KOREA FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL , 2018-2033 (USD THOUSAND)
TABLE 194 SOUTH KOREA RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 195 TAIWAN
TABLE 196 TAIWAN FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 197 TAIWAN FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 198 TAIWAN FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 199 TAIWAN CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 200 TAIWAN NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 201 TAIWAN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 202 TAIWAN FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 203 TAIWAN FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 204 TAIWAN FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 205 TAIWAN FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 206 TAIWAN FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 207 TAIWAN FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL , 2018-2033 (USD THOUSAND)
TABLE 208 TAIWAN RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 209 HONG KONG
TABLE 210 HONG KONG FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 211 HONG KONG FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 212 HONG KONG FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 213 HONG KONG CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 214 HONG KONG NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 215 HONG KONG FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 216 HONG KONG FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 217 HONG KONG FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 218 HONG KONG FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 219 HONG KONG FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 220 HONG KONG FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 221 HONG KONG FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 222 HONG KONG RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 223 REST OF APAC
TABLE 224 REST OF APAC FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 225 REST OF APAC FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 226 REST OF APAC FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 227 REST OF APAC CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 228 REST OF APAC NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 229 REST OF APAC FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 230 REST OF APAC FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 231 REST OF APAC FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 232 REST OF APAC FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 233 REST OF APAC FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 234 REST OF APAC FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 235 REST OF APAC FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL , 2018-2033 (USD THOUSAND)
TABLE 236 REST OF APAC RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 237 EUROPE FMD VACCINE MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)
TABLE 238 EUROPE FMD VACCINE MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)
TABLE 239 EUROPE
TABLE 240 EUROPE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 241 EUROPE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 242 EUROPE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 243 EUROPE CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 244 EUROPE NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 245 EUROPE FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 246 EUROPE FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 247 EUROPE FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 248 EUROPE FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 249 EUROPE FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 250 EUROPE FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 251 EUROPE FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 252 EUROPE RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 253 TURKEY
TABLE 254 TURKEY FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 255 TURKEY FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 256 TURKEY FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 257 TURKEY CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 258 TURKEY NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 259 TURKEY FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 260 TURKEY FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 261 TURKEY FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 262 TURKEY FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 263 TURKEY FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 264 TURKEY FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 265 TURKEY FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 266 TURKEY RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 267 RUSSIA
TABLE 268 RUSSIA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 269 RUSSIA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 270 RUSSIA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 271 RUSSIA CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 272 RUSSIA NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 273 RUSSIA FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 274 RUSSIA FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 275 RUSSIA FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 276 RUSSIA FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 277 RUSSIA FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 278 RUSSIA FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 279 RUSSIA FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 280 RUSSIA RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 281 GERMANY
TABLE 282 GERMANY FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 283 GERMANY FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 284 GERMANY FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 285 GERMANY CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 286 GERMANY NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 287 GERMANY FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 288 GERMANY FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 289 GERMANY FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 290 GERMANY FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 291 GERMANY FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 292 GERMANY FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 293 GERMANY FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 294 GERMANY RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 295 FRANCE
TABLE 296 FRANCE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 297 FRANCE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 298 FRANCE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 299 FRANCE CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 300 FRANCE NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 301 FRANCE FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 302 FRANCE FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 303 FRANCE FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 304 FRANCE FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 305 FRANCE FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 306 FRANCE FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 307 FRANCE FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 308 FRANCE RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 309 U.K.
TABLE 310 U.K. FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 311 U.K. FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 312 U.K. FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 313 U.K. CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 314 U.K. NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 315 U.K. FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 316 U.K. FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 317 U.K. FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 318 U.K. FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 319 U.K. FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 320 U.K. FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 321 U.K. FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 322 U.K. RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 323 ITALY
TABLE 324 ITALY FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 325 ITALY FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 326 ITALY FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 327 ITALY CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 328 ITALY NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 329 ITALY FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 330 ITALY FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 331 ITALY FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 332 ITALY FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 333 ITALY FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 334 ITALY FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 335 ITALY FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 336 ITALY RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 337 SPAIN
TABLE 338 SPAIN FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 339 SPAIN FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 340 SPAIN FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 341 SPAIN CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 342 SPAIN NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 343 SPAIN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 344 SPAIN FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 345 SPAIN FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 346 SPAIN FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 347 SPAIN FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 348 SPAIN FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 349 SPAIN FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 350 SPAIN RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 351 NETHERLANDS
TABLE 352 NETHERLANDS FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 353 NETHERLANDS FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 354 NETHERLANDS FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 355 NETHERLANDS CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 356 NETHERLANDS NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 357 NETHERLANDS FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 358 NETHERLANDS FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 359 NETHERLANDS FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 360 NETHERLANDS FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 361 NETHERLANDS FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 362 NETHERLANDS FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 363 NETHERLANDS FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 364 NETHERLANDS RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 365 BELGIUM
TABLE 366 BELGIUM FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 367 BELGIUM FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 368 BELGIUM FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 369 BELGIUM CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 370 BELGIUM NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 371 BELGIUM FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 372 BELGIUM FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 373 BELGIUM FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 374 BELGIUM FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 375 BELGIUM FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 376 BELGIUM FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 377 BELGIUM FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 378 BELGIUM RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 379 SWITZERLAND
TABLE 380 SWITZERLAND FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 381 SWITZERLAND FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 382 SWITZERLAND FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 383 SWITZERLAND CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 384 SWITZERLAND NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 385 SWITZERLAND FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 386 SWITZERLAND FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 387 SWITZERLAND FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 388 SWITZERLAND FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 389 SWITZERLAND FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 390 SWITZERLAND FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 391 SWITZERLAND FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 392 SWITZERLAND RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 393 SWEDEN
TABLE 394 SWEDEN FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 395 SWEDEN FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 396 SWEDEN FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 397 SWEDEN CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 398 SWEDEN NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 399 SWEDEN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 400 SWEDEN FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 401 SWEDEN FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 402 SWEDEN FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 403 SWEDEN FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 404 SWEDEN FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 405 SWEDEN FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 406 SWEDEN RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 407 NORWAY
TABLE 408 NORWAY FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 409 NORWAY FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 410 NORWAY FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 411 NORWAY CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 412 NORWAY NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 413 NORWAY FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 414 NORWAY FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 415 NORWAY FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 416 NORWAY FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 417 NORWAY FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 418 NORWAY FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 419 NORWAY FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 420 NORWAY RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 421 DENMARK
TABLE 422 DENMARK FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 423 DENMARK FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 424 DENMARK FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 425 DENMARK CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 426 DENMARK NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 427 DENMARK FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 428 DENMARK FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 429 DENMARK FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 430 DENMARK FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 431 DENMARK FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 432 DENMARK FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 433 DENMARK FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 434 DENMARK RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 435 FINLAND
TABLE 436 FINLAND FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 437 FINLAND FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 438 FINLAND FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 439 FINLAND CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 440 FINLAND NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 441 FINLAND FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 442 FINLAND FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 443 FINLAND FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 444 FINLAND FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 445 FINLAND FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 446 FINLAND FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 447 FINLAND FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 448 FINLAND RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 449 REST OF EUROPE
TABLE 450 REST OF EUROPE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 451 REST OF EUROPE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 452 REST OF EUROPE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 453 REST OF EUROPE CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 454 REST OF EUROPE NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 455 REST OF EUROPE FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 456 REST OF EUROPE FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 457 REST OF EUROPE FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 458 REST OF EUROPE FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 459 REST OF EUROPE FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 460 REST OF EUROPE FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 461 REST OF EUROPE FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 462 REST OF EUROPE RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 463 NORTH AMERICA FMD VACCINE MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)
TABLE 464 NORTH AMERICA FMD VACCINE MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)
TABLE 465 NORTH AMERICA
TABLE 466 NORTH AMERICA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 467 NORTH AMERICA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 468 NORTH AMERICA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 469 NORTH AMERICA CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 470 NORTH AMERICA NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 471 NORTH AMERICA FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 472 NORTH AMERICA FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 473 NORTH AMERICA FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 474 NORTH AMERICA FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 475 NORTH AMERICA FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 476 NORTH AMERICA FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 477 NORTH AMERICA FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 478 NORTH AMERICA RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 479 U.S.
TABLE 480 U.S. FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 481 U.S. FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 482 U.S. FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 483 U.S. CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 484 U.S. NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 485 U.S. FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 486 U.S. FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 487 U.S. FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 488 U.S. FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 489 U.S. FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 490 U.S. FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 491 U.S. FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 492 U.S. RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 493 MEXICO
TABLE 494 MEXICO FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 495 MEXICO FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 496 MEXICO FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 497 MEXICO CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 498 MEXICO NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 499 MEXICO FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 500 MEXICO FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 501 MEXICO FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 502 MEXICO FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 503 MEXICO FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 504 MEXICO FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 505 MEXICO FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 506 MEXICO RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 507 CANADA
TABLE 508 CANADA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 509 CANADA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 510 CANADA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 511 CANADA CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 512 CANADA NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 513 CANADA FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 514 CANADA FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 515 CANADA FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 516 CANADA FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 517 CANADA FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 518 CANADA FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 519 CANADA FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 520 CANADA RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 521 SOUTH AMERICA FMD VACCINE MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)
TABLE 522 SOUTH AMERICA FMD VACCINE MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)
TABLE 523 SOUTH AMERICA
TABLE 524 SOUTH AMERICA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 525 SOUTH AMERICA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 526 SOUTH AMERICA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 527 SOUTH AMERICA CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 528 SOUTH AMERICA NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 529 SOUTH AMERICA FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 530 SOUTH AMERICA FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 531 SOUTH AMERICA FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 532 SOUTH AMERICA FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 533 SOUTH AMERICA FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 534 SOUTH AMERICA FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 535 SOUTH AMERICA FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 536 SOUTH AMERICA RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 537 ARGENTINA
TABLE 538 ARGENTINA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 539 ARGENTINA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 540 ARGENTINA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 541 ARGENTINA CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 542 ARGENTINA NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 543 ARGENTINA FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 544 ARGENTINA FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 545 ARGENTINA FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 546 ARGENTINA FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 547 ARGENTINA FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 548 ARGENTINA FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 549 ARGENTINA FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 550 ARGENTINA RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 551 COLOMBIA
TABLE 552 COLOMBIA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 553 COLOMBIA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 554 COLOMBIA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 555 COLOMBIA CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 556 COLOMBIA NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 557 COLOMBIA FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 558 COLOMBIA FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 559 COLOMBIA FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 560 COLOMBIA FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 561 COLOMBIA FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 562 COLOMBIA FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 563 COLOMBIA FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 564 COLOMBIA RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 565 VENEZUELA
TABLE 566 VENEZUELA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 567 VENEZUELA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 568 VENEZUELA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 569 VENEZUELA CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 570 VENEZUELA NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 571 VENEZUELA FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 572 VENEZUELA FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 573 VENEZUELA FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 574 VENEZUELA FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 575 VENEZUELA FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 576 VENEZUELA FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 577 VENEZUELA FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 578 VENEZUELA RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 579 PARAGUAY
TABLE 580 PARAGUAY FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 581 PARAGUAY FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 582 PARAGUAY FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 583 PARAGUAY CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 584 PARAGUAY NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 585 PARAGUAY FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 586 PARAGUAY FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 587 PARAGUAY FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 588 PARAGUAY FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 589 PARAGUAY FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 590 PARAGUAY FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 591 PARAGUAY FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 592 PARAGUAY RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 593 ECUADOR
TABLE 594 ECUADOR FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 595 ECUADOR FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 596 ECUADOR FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 597 ECUADOR CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 598 ECUADOR NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 599 ECUADOR FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 600 ECUADOR FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 601 ECUADOR FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 602 ECUADOR FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 603 ECUADOR FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 604 ECUADOR FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 605 ECUADOR FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 606 ECUADOR RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 607 BOLIVIA
TABLE 608 BOLIVIA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 609 BOLIVIA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 610 BOLIVIA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 611 BOLIVIA CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 612 BOLIVIA NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 613 BOLIVIA FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 614 BOLIVIA FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 615 BOLIVIA FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 616 BOLIVIA FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 617 BOLIVIA FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 618 BOLIVIA FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 619 BOLIVIA FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 620 BOLIVIA RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 621 PERU
TABLE 622 PERU FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 623 PERU FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 624 PERU FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 625 PERU CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 626 PERU NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 627 PERU FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 628 PERU FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 629 PERU FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 630 PERU FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 631 PERU FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 632 PERU FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 633 PERU FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 634 PERU RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 635 BRAZIL
TABLE 636 BRAZIL FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 637 BRAZIL FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 638 BRAZIL FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 639 BRAZIL CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 640 BRAZIL NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 641 BRAZIL FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 642 BRAZIL FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 643 BRAZIL FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 644 BRAZIL FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 645 BRAZIL FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 646 BRAZIL FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 647 BRAZIL FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 648 BRAZIL RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 649 URUGUAY
TABLE 650 URUGUAY FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 651 URUGUAY FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 652 URUGUAY FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 653 URUGUAY CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 654 URUGUAY NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 655 URUGUAY FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 656 URUGUAY FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 657 URUGUAY FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 658 URUGUAY FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 659 URUGUAY FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 660 URUGUAY FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 661 URUGUAY FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 662 URUGUAY RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 663 CHILE
TABLE 664 CHILE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 665 CHILE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 666 CHILE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 667 CHILE CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 668 CHILE NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 669 CHILE FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 670 CHILE FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 671 CHILE FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 672 CHILE FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 673 CHILE FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 674 CHILE FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 675 CHILE FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 676 CHILE RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 677 REST OF SOUTH AMERICA
TABLE 678 REST OF SOUTH AMERICA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 679 REST OF SOUTH AMERICA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 680 REST OF SOUTH AMERICA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 681 REST OF SOUTH AMERICA CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 682 REST OF SOUTH AMERICA NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 683 REST OF SOUTH AMERICA FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 684 REST OF SOUTH AMERICA FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 685 REST OF SOUTH AMERICA FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 686 REST OF SOUTH AMERICA FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 687 REST OF SOUTH AMERICA FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 688 REST OF SOUTH AMERICA FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 689 REST OF SOUTH AMERICA FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 690 REST OF SOUTH AMERICA RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 691 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)
TABLE 692 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)
TABLE 693 MIDDLE EAST AND AFRICA
TABLE 694 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 695 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 696 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 697 MIDDLE EAST AND AFRICA CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 698 TABLE
TABLE 699 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 700 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 701 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 702 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 703 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 704 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 705 TABLE
TABLE 706 MIDDLE EAST AND AFRICA RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 707 SOUTH AFRICA
TABLE 708 SOUTH AFRICA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 709 SOUTH AFRICA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 710 SOUTH AFRICA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 711 SOUTH AFRICA CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 712 SOUTH AFRICA NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 713 SOUTH AFRICA FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 714 SOUTH AFRICA FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 715 SOUTH AFRICA FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 716 SOUTH AFRICA FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 717 SOUTH AFRICA FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 718 SOUTH AFRICA FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 719 SOUTH AFRICA FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL , 2018-2033 (USD THOUSAND)
TABLE 720 SOUTH AFRICA RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 721 EGYPT
TABLE 722 EGYPT FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 723 EGYPT FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 724 EGYPT FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 725 EGYPT CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 726 EGYPT NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 727 EGYPT FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 728 EGYPT FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 729 EGYPT FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 730 EGYPT FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 731 EGYPT FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 732 EGYPT FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 733 EGYPT FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL , 2018-2033 (USD THOUSAND)
TABLE 734 EGYPT RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 735 SAUDI ARABIA
TABLE 736 SAUDI ARABIA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 737 SAUDI ARABIA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 738 SAUDI ARABIA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 739 SAUDI ARABIA CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 740 SAUDI ARABIA NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 741 SAUDI ARABIA FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 742 SAUDI ARABIA FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 743 SAUDI ARABIA FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 744 SAUDI ARABIA FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 745 SAUDI ARABIA FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 746 SAUDI ARABIA FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 747 SAUDI ARABIA FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL , 2018-2033 (USD THOUSAND)
TABLE 748 SAUDI ARABIA RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 749 ISRAEL
TABLE 750 ISRAEL FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 751 ISRAEL FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 752 ISRAEL FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 753 ISRAEL CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 754 ISRAEL NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 755 ISRAEL FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 756 ISRAEL FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 757 ISRAEL FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 758 ISRAEL FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 759 ISRAEL FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 760 ISRAEL FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 761 ISRAEL FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL , 2018-2033 (USD THOUSAND)
TABLE 762 ISRAEL RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 763 UAE
TABLE 764 UAE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 765 UAE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 766 UAE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 767 UAE CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 768 UAE NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 769 UAE FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 770 UAE FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 771 UAE FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 772 UAE FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 773 UAE FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 774 UAE FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 775 UAE FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL , 2018-2033 (USD THOUSAND)
TABLE 776 UAE RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 777 KUWAIT
TABLE 778 KUWAIT FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 779 KUWAIT FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 780 KUWAIT FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 781 KUWAIT CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 782 KUWAIT NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 783 KUWAIT FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 784 KUWAIT FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 785 KUWAIT FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 786 KUWAIT FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 787 KUWAIT FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 788 KUWAIT FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 789 KUWAIT FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL 2018-2033 (USD THOUSAND)
TABLE 790 KUWAIT RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 791 OMAN
TABLE 792 OMAN FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 793 OMAN FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 794 OMAN FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 795 OMAN CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 796 OMAN NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 797 OMAN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 798 OMAN FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 799 OMAN FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 800 OMAN FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 801 OMAN FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 802 OMAN FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 803 OMAN FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL , 2018-2033 (USD THOUSAND)
TABLE 804 OMAN RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 805 QATAR
TABLE 806 QATAR FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 807 QATAR FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 808 QATAR FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 809 QATAR CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 810 QATAR NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 811 QATAR FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 812 QATAR FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 813 QATAR FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 814 QATAR FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 815 QATAR FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 816 QATAR FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 817 QATAR FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL , 2018-2033 (USD THOUSAND)
TABLE 818 QATAR RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 819 BAHRAIN
TABLE 820 BAHRAIN FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 821 BAHRAIN FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 822 BAHRAIN FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 823 BAHRAIN CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 824 BAHRAIN NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 825 BAHRAIN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 826 BAHRAIN FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 827 BAHRAIN FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 828 BAHRAIN FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 829 BAHRAIN FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 830 BAHRAIN FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 831 BAHRAIN FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL , 2018-2033 (USD THOUSAND)
TABLE 832 BAHRAIN RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 833 REST OF MEA
TABLE 834 REST OF MEA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 835 REST OF MEA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 836 REST OF MEA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 837 REST OF MEA CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 838 REST OF MEA NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 839 REST OF MEA FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 840 REST OF MEA FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 841 REST OF MEA FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 842 REST OF MEA FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 843 REST OF MEA FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 844 REST OF MEA FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 845 REST OF MEA FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL , 2018-2033 (USD THOUSAND)
TABLE 846 REST OF MEA RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
List of Figure
FIGURE 1 GLOBAL FMD VACCINE MARKET: SEGMENTATION
FIGURE 2 GLOBAL FMD VACCINE MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL FMD VACCINE MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL FMD VACCINE MARKET: GLOBAL VS REGIONAL ANALYSIS
FIGURE 5 GLOBAL FMD VACCINE MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL FMD VACCINE MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL FMD VACCINE MARKET: DBMR MARKET POSITION GRID
FIGURE 8 GLOBAL FMD VACCINE MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 GLOBAL FMD VACCINE MARKET : VENDOR SHARE ANALYSIS
FIGURE 10 EXECUTIVE SUMMARY
FIGURE 11 GLOBAL FMD VACCINE MARKET: SEGMENTATION
FIGURE 12 STRATEGIC DECISIONS
FIGURE 13 RISING PREVALENCE OF FOOT-AND-MOUTH DISEASE AND INCREASING GOVERNMENT-LED MASS VACCINATION PROGRAMS EXPECTED TO DRIVE THE GLOBAL FMD VACCINE MARKET IN THE FORECAST PERIOD OF 2026 TO 2033
FIGURE 14 CONVENTIONAL VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL FMD VACCINE MARKET IN 2026 & 2033
FIGURE 15 ASIS-PACIFIC IS EXPECTED TO DOMINATE THE GLOBAL FMD VACCINE MARKET AND GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2026 TO 2033
FIGURE 16 GLOBAL FMD VACCINE MARKET, REGIONAL ANALYSIS
FIGURE 17 STANDARD DOSING SCHEDULE OF FMD VACCINE
FIGURE 18 TOP ENTITIES BASED ON R&D GLANCE FOR GLOBAL FMD VACCINE MARKET
FIGURE 19 DROC ANALYSIS
FIGURE 20 GLOBAL FMD VACCINE MARKET, BY VACCINE TYPE
FIGURE 21 GLOBAL FMD VACCINE MARKET, BY VACCINE TYPE, 2025
FIGURE 22 GLOBAL FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2032
FIGURE 23 GLOBAL FMD VACCINE MARKET, BY VACCINE TYPE
FIGURE 24 GLOBAL FMD VACCINE MARKET, BY TYPE, 2025
FIGURE 25 GLOBAL FMD VACCINE MARKET, BY TYPE
FIGURE 26 GLOBAL FMD VACCINE MARKET, BY TYPE, 2018-2032
FIGURE 27 GLOBAL FMD VACCINE MARKET, BY TYPE
FIGURE 28 GLOBAL FMD VACCINE MARKET, BY VACCINATION ROUTE, 2025
FIGURE 29 GLOBAL FMD VACCINE MARKET, BY VACCINATION ROUTE
FIGURE 30 GLOBAL FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2032
FIGURE 31 GLOBAL FMD VACCINE MARKET, BY VACCINATION ROUTE
FIGURE 32 GLOBAL FMD VACCINE MARKET, BY ANIMAL TYPE, 2025
FIGURE 33 GLOBAL FMD VACCINE MARKET, BY ANIMAL TYPE
FIGURE 34 GLOBAL FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2032
FIGURE 35 GLOBAL FMD VACCINE MARKET, BY ANIMAL TYPE
FIGURE 36 GLOBAL FMD VACCINE MARKET, BY FORMULATION TYPE, 2025
FIGURE 37 GLOBAL FMD VACCINE MARKET, BY FORMULATION TYPE
FIGURE 38 GLOBAL FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2032
FIGURE 39 GLOBAL FMD VACCINE MARKET, BY FORMULATION TYPE
FIGURE 40 GLOBAL FMD VACCINE MARKET, BY APPLICATION, 2025
FIGURE 41 GLOBAL FMD VACCINE MARKET, BY APPLICATION
FIGURE 42 GLOBAL FMD VACCINE MARKET, BY APPLICATION, 2018-2032
FIGURE 43 GLOBAL FMD VACCINE MARKET, BY APPLICATION
FIGURE 44 GLOBAL FMD VACCINE MARKET, BY END USER, 2025
FIGURE 45 GLOBAL FMD VACCINE MARKET, BY END USER
FIGURE 46 GLOBAL FMD VACCINE MARKET, BY END USER, 2018-2032
FIGURE 47 GLOBAL FMD VACCINE MARKET, BY END USER
FIGURE 48 GLOBAL FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2025
FIGURE 49 GLOBAL FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL
FIGURE 50 GLOBAL FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032
FIGURE 51 GLOBAL FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL
FIGURE 52 GLOBAL FMD VACCINE MARKET SNAPSHOTS
FIGURE 53 GLOBAL FMD VACCINE MARKET: COMPANY SHARE 2025 (%)
FIGURE 54 NORTH AMERICA FMD VACCINE MARKET: COMPANY SHARE 2025 (%)
FIGURE 55 EUROPE FMD VACCINE MARKET: COMPANY SHARE 2025 (%)
FIGURE 56 ASIA-PACIFIC FMD VACCINE MARKET: COMPANY SHARE 2025 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
